Patientory, Inc. is a healthcare technology company based in Atlanta, Georgia, established in 2015. It offers a health data management platform that enables individuals to securely store, manage, and share their health information. The platform empowers patients to take control of their medical records and chronic illness management while facilitating better communication and support between healthcare providers and patients. By integrating a blockchain-enabled network, Patientory streamlines access to health data, enhances care coordination, and provides insights into health outcomes. This approach aims to democratize health data ownership, reduce healthcare costs, and improve overall patient engagement and health management.
Sano Genetics Limited is a health technology company based in Cambridge, United Kingdom, that operates a user-centric genetic data-sharing platform. Founded in 2017, the company enables individuals to contribute their genetic and health data for research purposes, thereby advancing personalized medicine and scientific understanding. It provides researchers with tools to analyze user-consented data, facilitating recruitment for studies and clinical trials. The platform supports research on a variety of genetic conditions and human traits, including common disorders such as eczema, diabetes, and depression, as well as rare diseases like muscular dystrophy. By allowing participants to share their genetic information, Sano Genetics aims to enhance the development of new treatments and cures in the field of medicine.
JOGO Health is a virtual care company that specializes in digital therapeutics aimed at treating pain, neuromuscular conditions, and pelvic floor disorders. The company utilizes a combination of an AI-driven mobile app and wearable wireless sensors to deliver clinically proven interventions. These technologies offer treatment protocols and interactive games designed to enhance muscle relaxation, movement coordination, and neuromuscular reeducation. By leveraging the brain's neuroplasticity, JOGO Health enables healthcare providers to improve patient adherence to rehabilitation, ultimately leading to better health outcomes for individuals suffering from conditions such as stroke, chronic pain, and pelvic health issues.
AKKURE is a patient-centric digital platform which uses AI to match patients’ data with the most relevant clinical trials. 80% of trials struggle to meet enrolment deadlines. AKKURE’s platform boosts enrolment and the chances of a successful trial with a more precise telemedicine network which personalizes patient access and rewards those patients for sharing their data.
Triomics is a generative AI-powered platform focused on enhancing the efficiency of clinical trials, particularly in the field of oncology. The company aims to accelerate trial enrollment and improve healthcare operations by addressing operational inefficiencies in data collection and patient recruitment. Leveraging its advanced AI technology, which is trained to understand health records and medical terminology, Triomics facilitates a more streamlined approach to clinical research. Its platform supports pharmaceutical companies and contract research organizations in conducting rapid and cost-effective trials, ultimately advancing oncology research and care.
ModoScript develops a B2B hardware SaaS solution focused on remote treatment monitoring and big data analytics to enhance medication and treatment protocol efficiency. The company specializes in high-cost specialty pharmaceuticals, particularly Oral Oncolytics, and aims to leverage treatment progress data to create more personalized and safer therapies. By targeting pharmaceutical companies, health insurance providers, and medical practices, ModoScript facilitates the delivery of remote treatment care for patients with cancer and other chronic conditions. Their customizable data analytics model allows for real-time assessment of treatment effectiveness while ensuring that patients can access the service at no cost. Distribution partners include mail-order specialty pharmacies and in-office integrated pharmacies. ModoScript is committed to improving patient outcomes and ensuring equitable access to high-quality care, regardless of patients' backgrounds or socioeconomic status.
Ampersand Health is focused on developing digital therapeutics for individuals with long-term inflammatory conditions. Based in London and incorporated in 2014, the company offers a comprehensive digital platform that includes the Ampersand Healthsuite, a management tool designed for patients, and Healthsuite for Clinicians, which supports clinician-led, patient-centered self-management. The platform utilizes behavioral science to deliver personalized therapy, featuring expert-led courses, self-management tracking, and clinical messaging. Ampersand Health aims to enhance patients' mental health and quality of life while also providing significant cost savings for healthcare providers by reducing overall healthcare utilization.
PayRx is a healthcare analytics and financial solutions provider focused on delivering advanced therapies and medicines to patients. The company specializes in creating a repository and analytics system that supports self-insured employers by offering on-demand risk coverage solutions. This enables healthcare payers to access expensive but potentially curative treatments, thereby improving patient outcomes and facilitating better management of healthcare costs. Through its innovative approach, PayRx aims to enhance the accessibility and affordability of advanced medical therapies.
KEEP, named TIME Best Inventions of 2020 and 2020 CES Innovation Award winner, is the first HIPAA compliant smart device and patient-centric platform protecting vulnerable family members from inadvertently accessing medications, aiding with the consistency of adherence, and enabling real-time intervention.
Lumia Health is a digital health company focused on enhancing the quality of life for individuals with cardiovascular and neurological conditions, specifically targeting orthostatic syndromes. The company develops sensor-enabled wearable technology, including an in-ear device that utilizes artificial intelligence to monitor blood flow to the head. This innovative approach helps patients better understand symptoms like dizziness, brain fog, headaches, and fatigue that can arise when standing. By providing timely and critical health data, Lumia Health empowers patients to take preventive measures against potential health issues. The company's offerings include health data analysis and tracking solutions, aimed at delivering essential insights for better health management.
Digbi Health, LLC is a healthcare company that provides digital therapeutics services focused on personalized nutrition and wellness. Based in Mountain View, California, with additional offices in Bengaluru, India, and Taguig, Philippines, the company leverages Precision Biology, incorporating genetics, gut microbiome analysis, and continuous glucose monitoring to address food-related health issues such as obesity, type 2 diabetes, gastrointestinal disorders, and mental health conditions. Its platform offers a comprehensive range of health programs, including weight loss diets and personalized food recommendations, supported by an online application that tracks key metrics like stress, energy, and weight. Recently, Digbi Health launched a nationwide virtual clinic to prescribe GLP drugs, enhancing its multi-condition care approach for individuals with multiple chronic conditions. The services are designed to be accessible through employer partnerships and are covered by insurance, promoting sustainable weight management and overall health improvement.
ZiO Health is a biotechnology company that focuses on transforming laboratory testing through its proprietary pocket-sized technology, which allows for point-of-care diagnostics. By combining advanced biosensor technology with machine learning algorithms, ZiO Health provides real-time testing results tailored to each patient's unique profile. This innovative approach enables users to measure, test, and detect the molecular composition of various substances, facilitating personalized health insights. The company's devices aim to optimize health management and enhance patient outcomes, allowing individuals to conduct quality home diagnostics and take proactive steps in preventing illness.
Manta Cares is a company dedicated to supporting cancer patients, survivors, and caregivers through a range of interactive tools and community services. The organization offers an engagement platform that includes features such as interactive maps, planners, podcasts, and newsletters designed to assist individuals in navigating the complexities of cancer treatment and recovery. By providing these resources, Manta Cares aims to keep the cancer community informed and organized, helping them to cope with the challenges they face during their journeys.
viO HealthTech is focused on addressing various women's health issues, including those related to conception, polycystic ovarian syndrome, diminished ovarian reserve, miscarriage risk, pregnancy complications, and menopause. The company has developed a cycle monitoring system that predicts and confirms ovulation while supporting the overall management of women's health. This system integrates patient data with clinician insights, enhanced by artificial intelligence for screening and remote monitoring of therapeutic interventions. Additionally, viO HealthTech's sensors measure core body temperature through skin and vaginal contact, allowing for comprehensive cycle tracking and the identification of potential fertility problems.
Nivi is a digital health company that enables every person to realize their aspirations for better health. Nivi accomplishes this through a relentless focus on providing on-demand, trusted, and actionable health information that enables every individual to make more informed and supported decisions about their health. For our customers in the non-profit, commercial, and public sectors, Nivi illuminates trends and patterns in the health journeys that individuals take from initial marketing engagement, to health content accessed, and finally to actions taken in seeking out health services, purchasing health products, or achieving a particular health goal. It is through these insights gleaned from askNivi accompaniment that enables our customers to tailor the services they offer to best meet the needs of the audiences they serve.
Health In Her HUE is a digital platform aimed at connecting Black women and women of color with culturally sensitive healthcare providers. The platform offers access to evidence-based health content that resonates with the cultural experiences of these communities. By leveraging technology, media, and community support, Health In Her HUE seeks to address and reduce racial health disparities, ultimately improving health outcomes for Black women. It provides a space for these women to comfortably engage with healthcare providers and fosters better communication within their communities regarding health matters.
Innsightful offers a comprehensive digital health solution aimed at managing and alleviating mental health challenges, particularly for students. The company develops wearable devices that monitor and detect symptoms of anxiety and stress, utilizing artificial intelligence and machine learning to provide automated, early detection of heightened stress levels. These devices integrate biometrics to give users personalized insights, fostering a deeper understanding of their mental health. Additionally, Innsightful facilitates access to therapists for tailored recommendations and progress assessments, transforming how individuals approach their mental well-being.
Health Care Originals Inc. is a company based in Rochester, New York, specializing in the development of innovative solutions for managing chronic respiratory diseases, particularly asthma. Founded in 2014, the company has designed a wearable device known as ADAMM, which is part of a comprehensive three-part system that includes a smartphone application and a web portal. This technology is aimed at identifying and monitoring precursor symptoms of asthma attacks, providing users with actionable insights for better management of their condition. Additionally, Health Care Originals offers services for clinical trials, direct-to-consumer applications, and telemedicine, enhancing the overall effectiveness of respiratory monitoring and management.
Twill is a healthcare platform focused on enhancing mental and physical wellness. It offers a software solution that employs web and mobile technology to evaluate users' happiness through both subjective and objective assessments. The platform includes various programs and games designed to promote healthier mindsets. By addressing issues such as stress, depression, anxiety, and social isolation, Twill aims to support individuals, employers, and care delivery systems in managing the challenges associated with chronic illness.
My Moves Matter is a company focused on developing a patient-centric, neuro-friendly engagement platform specifically for women diagnosed with Parkinson's disease. The platform serves as a digital self-care companion, offering personalized insights and strategies for managing symptoms effectively. Key features include guidance on medication timing, exercise, diet, hormonal fluctuations, and sleep tracking. Additionally, the platform enables users to share their health data with healthcare providers, facilitating optimized treatment and enhancing the overall care experience for patients.
Local Infusion operates an ambulatory infusion therapy center that specializes in delivering care for chronic autoimmune diseases. The company focuses on providing qualified pharmaceuticals sourced from U.S. companies within the infusion and healthcare sectors. By utilizing its platform, Local Infusion aims to enhance patient outcomes, streamline processes for physicians, and make treatments more affordable for all stakeholders involved.
Nalagenetics is a health-tech company focused on genetic testing and personalized healthcare solutions. Established in 2016, the company partnered with the Indonesian health ministry to distribute genetic test kits in Papua and West Papua, where testing identified that 20% of leprosy patients possess a gene linked to severe reactions to Dapsone, an anti-leprosy medication. This vital information aids healthcare professionals in making informed treatment decisions. Nalagenetics develops a personalized prescription platform that enhances prescription effectiveness through genetic testing and information management. This platform enables patients and healthcare providers to access tailored information, improving interactions with existing healthcare technologies and ultimately leading to better health outcomes.
GPx is a biotech company that revolutionizes remote chronic disease management with bloodless blood tests. It is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care. The company was founded in 2020 and is based in Boston, Massachusetts.
Celero Systems is a life sciences company focused on developing an innovative ingestible platform aimed at detecting and reversing opioid overdose. By providing timely and autonomous interventions, the company seeks to significantly reduce mortality and injury associated with opioid overdoses. Their technology includes smart capsules that monitor physiological conditions from within the gastrointestinal tract and deliver targeted treatments for various medical issues. This approach not only empowers physicians with crucial physiological data but also enhances patient care through improved monitoring, diagnosis, and treatment of life-threatening conditions. Celero Systems is committed to advancing digital health solutions that address critical healthcare challenges.
nference, Inc. is a biotechnology company that offers an AI-based software platform designed to synthesize fragmented biomedical knowledge from various sources, including biomedical literature, molecular data, and real-world datasets. Founded in 2013 and headquartered in Cambridge, Massachusetts, with additional offices in Bengaluru, Toronto, and Rochester, nference provides advanced neural network models for the automated extraction of insights from scientific, clinical, regulatory, and commercial datasets. The company focuses on facilitating drug discovery, life cycle management, and precision medicine, enabling healthcare professionals and biopharmaceutical companies to develop personalized diagnostics and treatments for patients. By transforming electronic medical record data into actionable insights, nference addresses critical challenges in drug discovery and clinical research, enhancing patient care through comprehensive biological and clinical understanding.
Centaur Labs specializes in medical data annotation services, aimed at enhancing medical decision-making and diagnostics. The company utilizes a platform that connects a global network of students and professionals, who compete to provide high-quality data labeling. This collaborative model ensures exceptional accuracy and scalability in annotating medical and scientific data. By analyzing medical cases and labeling data effectively, Centaur Labs contributes to the development of advanced medical AI technologies, ultimately helping patients achieve better healthcare outcomes while potentially reducing costs.
Varient is a patient-centric software application that provides reliable social resources & connects users with pharma experts for treatment of rare genetical diseases.
Promptly is a health data analytics company focused on collecting, integrating, and analyzing data related to patient outcomes. The company has developed proprietary technology that facilitates patient engagement and real-world data collection, allowing for the discovery of digital biomarkers linked to symptoms, adverse effects, and treatment outcomes. By partnering with innovative healthcare organizations, Promptly utilizes this health data to enhance the quality of care while reducing costs for patients. The technology not only anticipates patient experiences before treatment but also tracks progress during treatment and provides validated information about clinical conditions, symptoms, and recovery strategies. This approach empowers patients to better understand and monitor the outcomes of their medical treatments.
Umedeor Ltd is a technology company that develops a platform designed to enhance data access for medical research and healthcare delivery. Incorporated in 2017 and based in London, with an additional office in New York, Umedeor's platform facilitates the management of research and clinical programs for healthcare providers, care agencies, charities, and research organizations. By automating the creation of prospective, protocolized patient registries, Umedeor enables healthcare sites to engage in multiple research programs simultaneously without increasing operational burdens. The platform also provides life science companies with access to high-quality regulatory data, allowing for compliant re-engagement with patients to further research and development initiatives.
Biostrap is a business-to-business wearable health monitoring platform that leverages advanced machine learning and health analytics to provide comprehensive health insights. It offers an affordable solution for enterprises, enabling them to access a range of data-driven metrics, including oxygen saturation, respiration rate, heart rate variability, sleep analysis, and arterial health. Biostrap's dual-device technology allows for full-body activity tracking, empowering users to monitor their health conveniently from home. The platform's machine learning algorithms analyze repetitive activities, giving users actionable health data to improve their overall well-being. Additionally, Biostrap operates on a secure, HIPAA-compliant system, making it an appropriate choice for health-tech companies seeking reliable health monitoring solutions.
Huma.AI, Inc. is a technology company based in Palo Alto, California, that focuses on developing a knowledge automation platform designed to enhance efficiency in the healthcare and pharmaceutical industries. Founded in 2016, the company addresses the challenges posed by disparate systems and the vast amounts of unstructured data that complicate decision-making. By serving as a connector between data silos, Huma.AI enables users to access insights and actionable information through natural language queries. The platform is capable of extracting valuable insights from various document formats, allowing companies, scientists, and clinicians to make informed decisions quickly and effectively. Through this innovative approach, Huma.AI aims to streamline healthcare processes and improve overall operational efficiency.
HealthQb remotely monitors patients’ biopsychosocial health and empowers health providers, clinicians and practitioners (like your physiotherapist, your massage therapist and your osteopathic manual practitioner) who, armed with these objective assessments, guide you to your health goals.
Vistim Labs is a MedTech diagnostic company focused on addressing neurological disorders, particularly dementia and Alzheimer's disease. The company has developed an innovative AI-powered neurodiagnostic software that analyzes EEG data to detect brainwave patterns linked to the onset and progression of these conditions. This technology supports clinicians in providing earlier diagnosis and improving the efficiency of clinical trials, ultimately aiding in the development of effective treatments. Additionally, Vistim Labs offers the first noninvasive amyloid assessment, which is also reimbursed, further enhancing its capabilities in the realm of neurological diagnostics.
Deliberate AI focuses on advancing mental health care through its development of multimodal artificial intelligence technologies. The company specializes in regulatory-grade measurement tools that enhance diagnostics and monitoring for behavioral and mental health applications. Their platform employs AI algorithms to deliver objective assessments and insights, supporting clinicians, physicians, and researchers in mental and neurological healthcare and clinical trials. By enabling precision therapy and integrating ambient clinical intelligence, Deliberate AI aims to improve the quality of care and outcomes for patients undergoing mental health treatment.
Orbit Health is a health technology company that specializes in creating an artificial intelligence platform designed for the management of chronic diseases, particularly Parkinson's disease. The platform offers continuous and objective insights into motor symptoms by utilizing smartwatch motion data, which is collected passively without disrupting patients' daily activities. This innovative approach allows physicians to tailor treatments to individual patients, enhancing their ability to achieve optimal symptom control and improving their overall quality of life.
WKD.SMRT provides a platform that combines remote interaction with state-of-the-art digital technologies to deliver accurate and complete real-world data. They integrates data in the home with third party data and conventional clinical examinations.
Accexible is a technology company that specializes in developing a speech analysis platform aimed at the early detection of mental health conditions. The platform utilizes artificial intelligence to extract vocal biomarkers from speech, which are specific characteristics that provide insights into an individual's health and well-being. By identifying these vocal traits, Accexible's technology enables healthcare professionals to diagnose and monitor various diseases, particularly mild cognitive impairment and mild dementia. The platform can be integrated into existing healthcare care plans, enhancing the ability to identify potential health issues efficiently.
REACT Neuro is a digital healthcare company based in Cambridge, Massachusetts, focused on advancing brain health through an artificial intelligence-driven platform. This platform includes a range of clinically validated assessments that evaluate patients' brain health using digital biomarkers. REACT Neuro offers personalized virtual reality services that incorporate eye-tracking, voice recognition, and movement analysis, enhancing the understanding of neurocognitive function. By employing multimodal neurophysiological phenotyping, the company aims to provide objective measurements of brain health, supporting healthy aging and overall wellness.
modus health™ our mission is to accurately measure treatment outcomes, provide actionable physical activity data and analytics to inform clinical decisions, and improve healthcare efficiencies where mobility plays a key role in recovery. They focus on patient segments with slow or irregular gait in which our StepWatch™ technology is uniquely accurate in measuring physical activity.
Neuroventis operates as a digital platform for neurology. The Neuroventis platform is a CE-marked medical device that aims to help patients manage and register their neurological disorders and share their health data with their medical team.
Nori is a chatbot coach for people that live with a chronic disease. She will help to identify and change what is making you sick through regular conversations. By making lifestyle changes that impact the severity of the disease, Nori helps to find better quality of life.
Droice Labs specializes in developing artificial intelligence-based middleware software aimed at enhancing decision-making for healthcare providers. The company's technology effectively processes messy and noisy real-world patient data, which includes electronic medical records, laboratory results, and claims, as well as unstructured content. By transforming this data into analysis-ready formats, Droice Labs supports innovative clinical and research applications. This approach enables healthcare professionals to improve patient outcomes and optimize patient flow within health systems.
Tag.bio, Inc., founded in 2013 and based in San Francisco, California, specializes in providing information technology solutions for the healthcare and life sciences sectors. The company has developed a data science platform that facilitates the discovery, sharing, and unification of diverse siloed data sets through a no-code/low-code data mesh framework. This platform enables organizations to execute workloads and derive insights securely by transforming data into products. It integrates various data sets with smart APIs and incorporates statistical and machine learning algorithms, allowing users to access insights via applications or generative AI solutions. Tag.bio's offerings are available on major cloud marketplaces, including AWS and Azure.
Longenesis operates a blockchain-based personal data marketplace that focuses on securely storing and monetizing health data. The platform transforms personal health information into a token, which facilitates currency generation and ensures secure data management. This innovative approach not only enables pharmaceutical companies to develop new drugs but also allows individuals to sell their data privately and securely. By fostering direct interactions between buyers and sellers, Longenesis aims to create a more efficient and trustworthy environment for data exchange within the healthcare sector.
Neuroute is an AI-driven platform that enhances the efficiency of clinical trials by optimizing patient recruitment. It offers a web-based solution that empowers healthcare professionals to connect with patients and streamline clinical development processes. By utilizing artificial intelligence, Neuroute generates targeted patient recruitment strategies and campaigns, which aim to improve outcomes for both patients and clinical innovators. The company is supported by prominent pharmaceutical firms, including Astrazeneca, Pfizer, Novo Nordisk, Boehringer Ingelheim, Takeda, Roche, and Eli Lilly, highlighting its credibility and commitment to advancing healthcare.
Prism helps life science teams organize their documents, unlock new insights, and efficiently communicate with our intuitive, highly-configurable knowledge management software.
Liyfe operates a remote symptom management platform designed to automate the triage pathways used by oncology nurses and to identify high-risk patients. The platform provides education to patients on managing symptoms at home and proactively assesses their nutritional and emotional needs. By utilizing an evidence-based, standardized symptom triage protocol, Liyfe enables patients to report their symptoms and submit queries, thereby facilitating better communication and care management. The company's focus is on enhancing the patient experience while improving the efficiency of symptom assessment and risk prediction in oncology and NASH (non-alcoholic steatohepatitis).
Seascape Clinical provides a cloud platform that oversees trials and automates work. They simplify clinical trial oversight by consolidating inputs from disparate data sources and producing accurate, updated dashboards and trackers to facilitate decision-making for clinical operations teams.
The Clinician is a Health IT company with a focus on driving better care outcomes while improving organisational efficiency and reducing costs. With hubs in New Zealand and Singapore The Clinician is swiftly gaining a reputation as the first mover in this vertical in Asia Pacific. The management team is internationally experienced who are experts in their individual fields and have held senior level positions in medicine, engineering, research and business intelligence.The Clinician’s flagship product is ZEDOC - a cloud based Software as a Service (SaaS) platform that operates within existing clinical workflows, communicating directly with both patients and care teams, to enable collection and analysis of Patient Reported Outcome Measures (PROMs) throughout the care continuum in the clinic or remotely between visits. The solution seamlessly gathers data from health tracker devices and wearables throughout the patient journey.
SmartTab is a pharmaceutical company based in Denver, Colorado, founded in 2015. It specializes in developing innovative drug delivery and monitoring systems through its wireless ingestible capsule technology. This platform includes an electronic receiver, smart polymer actuator, and active ingredients, aimed at enhancing patient outcomes and medication compliance. SmartTab's offerings include three drug delivery platforms: TargetTab™, InjectTab™, and MultiTab™. The technology utilizes inductive power and monitoring to optimize therapies based on statistical data, ensuring low toxicity and facilitating integration with the Internet of Medical Things. This approach enables healthcare providers to deliver targeted medication effectively.
nQ Medical is a digital therapeutics company addressing neurocognitive and neuromotor disorder via 24/7, passive data collection via personal devices. It is a frictionless, non-invasive, early detection, remote disease progression monitoring, and therapeutic measurement modality. nQ uses an artificial intelligence company to develop computational biomarkers that have been proven in five years of clinical trials to substantially change the way disease is managed for a wide range of neuromotor and neurocognitive disorders (Alzhemer's, Parkinson's, Multiple Sclerosis, ALS, concussion, et al. The platfomr focuses on analysis of user interaction with common electronic devices to capture functional decline related to neurodegenerative disorders. The fine control of typing and touch screen kinematics together with the frequent use of electronic devices allows for precise monitoring of small changes in neurodegeneration that frequently go unnoticed by clinicians. nQ allows for early detection of disease, 24/7, passive, at home, remote monitoring of disease progression and the measurement of impact of therapy at a fraction of the cost of current gold standards. There is no required task. Just use your device as your would normally use it. Of note, as one of the company's medical advisors, Zoltan Mari, MD, of the Cleveland Clinic, so aptly quoted: "As important as it is to fund novel compounds for treating diseases, it is also important to set the stage for maximum impact when those compounds are discovered and approved for use. It is impossible to find a cure without early detection. That's why drug candidates fail. When the FDA puts its stamp on the first disease modifying drugs, such early detection technologies will be instantly necessary." He goes on to state further: "We also need a disease progression marker. Nothing so far has managed to do very well (while being profoundly expensive). Much of our research and clinical interest is turning toward disease progression. All efforts should focus on readying and perfecting early detection tools and building effective, reliable, inexpensive ways of tracking disease and the impact of therapy over time.” nQ is that early detection, disease progression computational biomarker.
What if we could early detect diseases and monitor health with nothing more than our voice? We are on our mission to unlock the human voice as a prognostic and diagnostic marker for the early-detection of diseases and enable humanity to life a longer and healthier life. EVOCAL Health is developing sophisticated Healthcare Intelligence Algorithms based on Artificial Intelligence and Machine Learning, that uses Vocal Biomarkers like voice-, breathing- and coughing noises to detect diseases. Vocal Biomarkers have the potential to transform the way we detect and treat diseases through their accuracy, speed and cost-effectiveness. Unlike conventional testing methods, our vision is to use cost-effective everyday technologies like smartphones and enable a broad part of the population to detect and be diagnosed with Vocal Biomarkers on-scale, globally and wherever they are.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.